At Apotex, we push the boundaries of healthcare with an unwavering commitment, making treatments accessible through innovations, affordability, and care. We forge partnerships that spark breakthroughs, empower communities, and create lasting impact. And through transparency and dedication, our people remain united in putting better health within reach for all.
Supplemented PREP prospectus and any amendment will be accessible through SEDAR+ within two business days Toronto, Ontario, June 10, 2026 - Apotex Health Corp. ("Apotex" or the "Company") today...
Toronto, Ontario, June 9, 2026 - Apotex Health Corp. ("Apotex" or the "Company") today announced the upsize of its previously announced initial public offering (the "Offering") of common shares of...
Jun 3, 2026 Weston, Florida - June 03, 2026 — Apotex Corp. ("Apotex") today announced the U.S. launch of sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, both of which...
